Dioxydin^®

Due to the mechanism of action, it reduces the risk of pathogen resistance to the drug.

• The microbiological efficacy of Dioxidyn is 93%, including strains of microorganisms resistant to antibiotics¹.
• No cases of cross-resistance with antibiotics have been described, which allows it to be used in cases of polyresistance of bacterial flora¹.
• Increase of antimicrobial activity in oxygen-free conditions up to 100 times².

Indications for use³

In otorhinolaryngology:

• Acute purulent otitis media with perforation.
• Exacerbation of chronic purulent otitis media.
• Acute tonsillopharyngitis.
• Exacerbation of chronic tonsillitis.

In outpatient surgery:

• Superficial and deep wounds of various localization.
• Long-term non-healing wounds and trophic ulcers.
• Phlegmons of soft tissues, infected burns.

In hospital surgery:

• Purulent processes in the thoracic and abdominal cavity.
• Purulent pleurisy, pleural empyema, lung abscesses.
• Peritonitis, cystitis.
• Wounds with deep purulent cavities.
• Prevention of infectious complications after catheterization of the bladder.

¹ Popov D.A. et al. "Dioxidyn: antimicrobial activity and prospects for clinical use at the present stage" // Antibiotics and chemotherapy // 2013, 58; 3-4, pp. 38-43.

² E.N. Padeyskaya. Antibacterial drug dioxidyn: features of biological action and significance in the treatment of various forms of purulent infection // Infections and antimicrobial therapy, 2001, 5, 150-5.

³Instructions for the medical use of the drug Dioxidin Reg.ud. No. LP-No.(000404)-(RG-RU) from 11/22/2022.

⁴ Guskova T.A. et al. Antimicrobial activity of dioxidin against strains of potential pathogens of otorhinolaryngological infections. Chemical and Pharmaceutical journal. 2016;7:35-9.